Distalmotion on a continued growth momentum in the US
Over the past months, Distalmotion has experienced a strong wave of successful customer acquisitions, with most recently achieving the first multi-robot sale in the United States. AdventHealth, which operates 50 hospitals in nine states, has selected the DEXTER Robotic Surgery System, with the first cases already completed with the system.
As demand for surgical robotics continues to rise and more high-volume soft tissue procedures, such as inguinal hernia repair and cholecystectomy, move into outpatient settings, healthcare facilities are seeking solutions that match their clinical and operational needs. However, their focus on efficiency and patient experience makes existing soft tissue robots impractical due to size, operational complexity, and costs.
DEXTER, with its small format and mobile design, integrates into any operating room and can be easily maneuvered between rooms, helping reduce turnover time and maximize throughput. It is the only system available in the US and European markets with both a sterile console and fully open architecture. The sterile console enables flexible workflows by allowing surgeons to perform bedside tasks and then immediately return to robotic operation without a change in sterility or re-docking of the robot. Its open architecture supports the use of preferred instruments and OR technologies that are already available in the facility.
As part of its US expansion, Distalmotion has won over AdventHealth, a not-for-profit, faith-based health care organization, operating over 50 hospitals and hundreds of care sites across nine states – marking the startup’s first multi-robot sale in the country. The multiple Dexter systems will support the growth of minimally invasive surgery in AdventHealth’s outpatient department.
“We’re excited to have completed our first cases with Dexter as we bring robotic surgery to our outpatient department. As we expand our capabilities, we’re focused on solutions that align with our goals for flexibility and efficiency,” said Dr. Carlos Ortiz-Ortiz MD, FACS, General Surgeon at AdventHealth Celebration.
“This multi-system sale underscores how health systems are seeking more flexible solutions that bring the benefits of robotics to operating rooms (ORs) across their sites of care,” said Greg Roche, CEO of Distalmotion. “DEXTER is designed to meet the realities of outpatient surgery, without compromising existing practices.”
This milestone builds on Distalmotion’s growing footprint in the US and Europe, with more than 2,000 procedures completed globally across general, gynecological, and urological specialties. The company remains focused on making robotic surgery more accessible across more sites of care globally.
(Press release/RAN)